- Exchange: Hong Kong
- Sector: Consumer, Cyclical
- Industry: Retail
- Sub-Industry: Retail-Drug Store
Shanghai Pharmaceuticals Holding Co Ltd
+ Add to Watchlist2607:HK
15.060 HKD 0.540 3.72%As of 04:01:04 ET on 05/24/2013.
Snapshot for Shanghai Pharmaceuticals Holding Co Ltd (2607)
| Open: | 14.540 | Day's Range: | 14.500 - 15.140 | Volume: | 3,771,536 |
|---|---|---|---|---|---|
| Previous Close: | 15.060 | 52wk Range: | 8.750 - 17.860 | 1-Yr Rtn: | +66.16% |
Key Statistics for 2607
| Current P/E Ratio (ttm) | 15.6513 |
|---|---|
| Estimated P/E(12/2013) | 14.1090 |
| Relative P/E vs. HSI | 1.5232 |
| Earnings Per Share (CNY) (ttm) | 0.7600 |
| Est. EPS (CNY) (12/2013) | 0.8430 |
| Est. PEG Ratio | 0.6719 |
| Market Cap (M HKD) | 42,065.43 |
| Shares Outstanding (M) | 765.89 |
| 30 Day Average Volume | 3,447,565 |
| Price/Book (mrq) | 1.2981 |
| Price/Sale (ttm) | 0.4698 |
| Dividend Indicated Gross Yield | 2.02% |
| Cash Dividend (CNY) | 0.2160 |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 2607
Company Profile & Key Executives for 2607
Shanghai Pharmaceuticals Holding Co., Ltd. manufactures, retails, and wholesales a variety of pharmaceuticals including biopharmaceuticals, chemical and Chinese traditional medicines, and healthcare products. The Company also invests in new medicine development and provides related services.
| Zhou JieChairman/Executive Director | Zhang JialinVice Chairman/Exec Dir |
| Xu GuoxiongPresident/Executive Director | Jiang YuanyingVice President |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
2607 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page